236 related articles for article (PubMed ID: 34257595)
1. Potential Prognostic Value of Preoperative Leukocyte Count, Lactate Dehydrogenase and C-Reactive Protein in Thymic Epithelial Tumors.
Valdivia D; Cheufou D; Fels B; Puhlvers S; Mardanzai K; Zaatar M; Weinreich G; Taube C; Theegarten D; Stuschke M; Schuler M; Stamatis G; Hegedus B; Aigner C
Pathol Oncol Res; 2021; 27():629993. PubMed ID: 34257595
[TBL] [Abstract][Full Text] [Related]
2. High Neutrophil Count as a Negative Prognostic Factor for Relapse in Patients with Thymic Epithelial Tumor.
Okada S; Shimomura M; Tsunezuka H; Ishihara S; Ikebe S; Furuya T; Shimada J; Teramukai S; Inoue M
Ann Surg Oncol; 2020 Jul; 27(7):2438-2447. PubMed ID: 31993857
[TBL] [Abstract][Full Text] [Related]
3. Elevated CRP levels predict poor outcome and tumor recurrence in patients with thymic epithelial tumors: A pro- and retrospective analysis.
Janik S; Bekos C; Hacker P; Raunegger T; Ghanim B; Einwallner E; Beer L; Klepetko W; Müllauer L; Ankersmit HJ; Moser B
Oncotarget; 2017 Jul; 8(29):47090-47102. PubMed ID: 28514756
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of tumour size in completely resected thymic epithelial tumours.
Fukui T; Fukumoto K; Okasaka T; Kawaguchi K; Nakamura S; Hakiri S; Ozeki N; Hirakawa A; Tateyama H; Yokoi K
Eur J Cardiothorac Surg; 2016 Dec; 50(6):1068-1074. PubMed ID: 27999073
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment serum neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios: Two tumor-related systemic inflammatory markers in patients with thymic epithelial tumors.
Wang L; Ruan M; Yan H; Lei B; Sun X; Chang C; Liu L; Xie W
Cytokine; 2020 Sep; 133():155149. PubMed ID: 32512341
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of a new tumour-node-metastasis staging system for thymic malignancies proposed by the International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee and the International Thymic Malignancy Interest Group.
Fukui T; Fukumoto K; Okasaka T; Kawaguchi K; Nakamura S; Hakiri S; Ozeki N; Hirakawa A; Tateyama H; Yokoi K
Eur J Cardiothorac Surg; 2016 Feb; 49(2):574-9. PubMed ID: 26547095
[TBL] [Abstract][Full Text] [Related]
7. Surgical outcomes of 215 patients with thymic epithelial tumors: A single-center experience.
Tian W; Sun Y; Wu Q; Jiao P; Ma C; Yu H; Huang C; Tong H
Thorac Cancer; 2020 Jul; 11(7):1840-1847. PubMed ID: 32384230
[TBL] [Abstract][Full Text] [Related]
8. Postoperative radiotherapy is effective for thymic carcinoma but not for thymoma in stage II and III thymic epithelial tumors: the Japanese Association for Research on the Thymus Database Study.
Omasa M; Date H; Sozu T; Sato T; Nagai K; Yokoi K; Okamoto T; Ikeda N; Tanaka F; Maniwa Y;
Cancer; 2015 Apr; 121(7):1008-16. PubMed ID: 25565590
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors of stage I thymic epithelial tumors.
Fukui T; Kadomatsu Y; Tsubouchi H; Nakanishi K; Ueno H; Sugiyama T; Goto M; Ozeki N; Nakamura S; Chen-Yoshikawa TF
Gen Thorac Cardiovasc Surg; 2021 Jan; 69(1):59-66. PubMed ID: 32621280
[TBL] [Abstract][Full Text] [Related]
10. Comparison of outcomes between neuroendocrine thymic tumours and other subtypes of thymic carcinomas: a joint analysis of the European Society of Thoracic Surgeons and the International Thymic Malignancy Interest Group.
Filosso PL; Yao X; Ruffini E; Ahmad U; Antonicelli A; Huang J; Guerrera F; Venuta F; van Raemdonck D; Travis W; Lucchi M; Rimner A; Thomas P; Weder W; Rocco G; Detterbeck F; Korst R
Eur J Cardiothorac Surg; 2016 Oct; 50(4):766-771. PubMed ID: 27032473
[TBL] [Abstract][Full Text] [Related]
11. The Prognostic Role of the Number of Involved Structures in Thymic Epithelial Tumors: Results from the ESTS Database.
Chiappetta M; Lococo F; Sassorossi C; Aigner C; Ploenes T; Van Raemdonck D; Vanluyten C; Van Schil P; Agrafiotis AC; Guerrera F; Lyberis P; Casiraghi M; Spiaggiari L; Zisis C; Magou C; Moser B; Bauer J; Thomas PA; Brioude G; Passani S; Zsanto Z; Sperduti I; Margaritora S
Ann Surg Oncol; 2024 Jul; 31(7):4298-4307. PubMed ID: 38530530
[TBL] [Abstract][Full Text] [Related]
12. Behind and Beyond the Masaoka Staging: A 25-Year Follow-up Study of Tumor Recurrence in Completely Resected Thymic Epithelial Tumors in a Single Institution.
Tseng YL; Chang JM; Lai WW; Chang KC; Lee SC; Lin SH; Yen YT
Medicine (Baltimore); 2015 Dec; 94(52):e2278. PubMed ID: 26717364
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic reproducibility of thymic epithelial tumors using the World Health Organization classification: note for thoracic clinicians.
Sakakura N; Tateyama H; Nakamura S; Taniguchi T; Usami N; Ishikawa Y; Kawaguchi K; Yokoi K
Gen Thorac Cardiovasc Surg; 2013 Feb; 61(2):89-95. PubMed ID: 23229995
[TBL] [Abstract][Full Text] [Related]
14. Factors predicting recurrence in thymic epithelial neoplasms.
Alkaaki A; Abo Al-Saud A; Di Lena É; Ramirez-GarciaLuna JL; Najmeh S; Spicer J; Ferri L; Mulder D; Sirois C; Cools-Lartigue J
Eur J Cardiothorac Surg; 2022 Oct; 62(5):. PubMed ID: 35471455
[TBL] [Abstract][Full Text] [Related]
15. ¹⁸F-fluorodeoxyglucose positron emission tomography for evaluation of thymic epithelial tumors: utility for World Health Organization classification and predicting recurrence-free survival.
Seki N; Sakamoto S; Karube Y; Oyaizu T; Ishihama H; Chida M
Ann Nucl Med; 2014 Apr; 28(3):257-62. PubMed ID: 24430867
[TBL] [Abstract][Full Text] [Related]
16. [Clinical outcome of epithelial tumors of the thymus].
Tsukada H; Koike J; Osada H
Kyobu Geka; 2002 Oct; 55(11):936-41. PubMed ID: 12391689
[TBL] [Abstract][Full Text] [Related]
17. FDG PET-CT aids in the preoperative assessment of patients with newly diagnosed thymic epithelial malignancies.
Benveniste MF; Moran CA; Mawlawi O; Fox PS; Swisher SG; Munden RF; Marom EM
J Thorac Oncol; 2013 Apr; 8(4):502-10. PubMed ID: 23446204
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of the preoperative neutrophil-to-lymphocyte ratio for complete resection of thymoma.
Yanagiya M; Nitadori JI; Nagayama K; Anraku M; Sato M; Nakajima J
Surg Today; 2018 Apr; 48(4):422-430. PubMed ID: 29063371
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive study of clinicopathological and immune cell infiltration and lactate dehydrogenase expression in patients with thymic epithelial tumours.
Ying J; Huang Y; Ye X; Zhang Y; Yao Q; Wang J; Yang X; Yu C; Guo Y; Zhang X; Lv Q; Wang C; Mao W; Zhao A
Int Immunopharmacol; 2024 Jan; 126():111205. PubMed ID: 38029550
[TBL] [Abstract][Full Text] [Related]
20. [Correlation between Serum Cytokeratin 19 Fragment and the Clinicopathological Features and Prognosis of Thymic Epithelial Tumors].
Zhang X; Ji C; Gu Z; Fang W
Zhongguo Fei Ai Za Zhi; 2018 Jul; 21(7):519-525. PubMed ID: 30037371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
